HEALTHCARE RESOURCE UTILIZATION IN PATIENTS TREATED WITH EMPAGLIFLOZIN IN EAST ASIA: RESULTS FROM EMPRISE STUDY

被引：0
|
作者：
Sheu, Wayne [1 ]
Seino, Yutaka [1 ]
Tan, Elise [1 ]
Yabe, Daisuke [1 ]
Ha, Kyoung Hwa [1 ]
Chung, Wook-Jin [1 ]
Taneda, Yusuke [1 ]
Lei, Wei-Yu [1 ]
Ustyugova, Anastasia [1 ]
Klement, Riho [1 ]
Deruaz-Luyet, Anouk [1 ]
Kyaw, Moe [1 ]
Kim, Dae Jung [1 ]
机构：
[1] Boehringer Ingelheim Pharmaceut Inc, EMPRISE East Asia Study Grp, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1470 / 1470
页数：1
相关论文
共 50 条
  • [31] HEALTHCARE RESOURCE UTILIZATION OF SEVERE EOSINOPHILIC ASTHMA PATIENTS TREATED WITH BENRALIZUMAB IN REAL-LIFE: RESULTS FROM THE PORTUGUESE BETREAT STUDY
    Chaves-Loureiro, C.
    Carrico, F.
    Brito, U.
    Belchior, I
    Fernandes, R. A.
    Sousa, N.
    Mendes, A.
    Loureiro, C.
    Pardal, C.
    Ribeiro, L.
    Reis, G.
    Pires, N.
    Teles, C.
    Placido, J.
    Boaventura, R.
    Lima, R.
    Pardal, M.
    Marques, A.
    Martinho, H.
    Bernardo, F.
    VALUE IN HEALTH, 2023, 26 (12) : S302 - S302
  • [32] Empagliflozin and the risk of Gout: Analysis from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Koeneman, Lisette
    Tesfaye, Helen
    Paik, Julie M.
    Zabotka, Luke E.
    Htoo, Phyo T.
    Schmedt, Niklas
    Seman, Leo
    Wexler, Deborah J.
    Patorno, Elisabetta
    INNERE MEDIZIN, 2024, 65 : S145 - S145
  • [33] ANNUAL COST SAVINGS FROM THE USE OF EMPAGLIFLOZIN OVER DPP4I IN SELECT ASIA-PACIFIC COUNTRIES - ESTIMATES BASED ON THE EMPRISE EAST ASIA STUDY
    Varghese, L.
    Alcantara, G.
    Germanos, P.
    Sumettavanich, Y.
    Das, A.
    Don, Go J.
    VALUE IN HEALTH, 2022, 25 (12) : S139 - S139
  • [34] Empagliflozin and the Risk of Gout-Analysis from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Tesfaye, Helen
    Paik, Julie M.
    Zabotka, Luke
    Htoo, Phyo T.
    Schmedt, Niklas
    Koeneman, Lisette
    Seman, Leo J.
    Wexler, Deborah J.
    Patorno, Elisabetta
    DIABETES, 2023, 72
  • [35] Empagliflozin Selected Cardiovascular and Safety Outcomes in Routine Care: First Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Franklin, Jessica
    Najafzadeh, Mehdi
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Sambevski, Steven
    Bessette, Lily G.
    Kulldorff, Martin
    Schneeweiss, Sebastian
    DIABETES, 2019, 68
  • [36] Health Care Utilization and Cost Associated with Empagliflozin in Older Adults with Type 2 DiabetesResults from the EMPRISE study
    Htoo, Phyo T.
    Tesfaye, Helen
    Schneeweiss, Sebastian
    Wexler, Deborah J.
    Glynn, Robert
    Schmedt, Niklas
    Deruaz-Luyet, Anouk
    Koeneman, Lisette
    Paik, Julie M.
    Patorno, Elisabetta
    DIABETES, 2023, 72
  • [37] Healthcare Resource Utilization Among Patients Treated with Perampanel: A Retrospective UK Database Study
    Varga, S.
    Tsong, W.
    Jenkins-Jones, S.
    Holden, S.
    Morgan, C. L.
    EPILEPSIA, 2018, 59 : S274 - S274
  • [38] Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Karasik, Avraham
    Lanzinger, Stefanie
    Tan, Elise Chia -Hui
    Yabe, Daisuke
    Kim, Dae Jung
    Sheu, Wayne H. -H
    Melzer-Cohen, Cheli
    Holl, Reinhard W.
    Ha, Kyoung Hwa
    Khunti, Kamlesh
    Zaccardi, Francesco
    Subramanian, Anuradhaa
    Nirantharakumar, Krishnarajah
    Nystrom, Thomas
    Niskanen, Leo
    Jensen, Majken Linnemann
    Hoti, Fabian
    Klements, Riho
    Deruaz-Luyet, Anouk
    Kyaw, Moe H.
    Koeneman, Lisette
    Vistisen, Dorte
    Carstensen, Bendix
    Halvorsen, Sigrun
    Langslet, Gisle
    Farsani, Soulmaz Fazeli
    Patorno, Elisabetta
    Nunez, Julio
    DIABETES & METABOLISM, 2023, 49 (02)
  • [39] Reduction in Healthcare Resource Utilisation in Patients Treated With OnabotulinumtoxinA for Chronic Migraine: Results From the REPOSE Study
    Kollewe, Katja
    Antonakakis, Angela
    Kiszka, Michael
    Sommer, Katherine
    Yu, Justin S.
    CEPHALALGIA, 2019, 39 : 21 - 22
  • [40] COMPARATIVE EFFECTIVENESS AND SAFETY OF EMPAGLIFLOZIN: AN INTERIM ANALYSIS FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY
    Patorno, Elisabetta
    Pawar, Ajinkya
    Franklin, Jessica M.
    Najafzadeh, Mehdi
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly G.
    Bessette, Lily G.
    Kulldorff, Martin
    Schneeweiss, Sebastian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 683 - 683
12345